Impax Buyouts Add Plant, Portfolio And Pipeline
This article was originally published in The Pink Sheet Daily
Executive Summary
By acquiring three interrelated, privately held companies, Impax adds several branded and generic products, a substantial generic pipeline and an FDA-licensed manufacturing site in New Jersey.